Boehringer Ingelheim introduces NexGard SPECTRA for dogs in India
Apr 18, 2024
Mumbai (Maharashtra) [India], April 18: Boehringer Ingelheim, a global leader in animal health, announced the launch of NexGard SPECTRA® (afoxolaner and milbemycin oxime) in India, following its approval by the Central Drugs Standard Control Organisation (CDSCO). After the successful launches of its blockbuster NexGard range of products - NexGard® X and L in 2020 and NexGard® S and M (afoxolaner) in 2023, this represents an expansion of the NexGard® product line for dogs aged between two months and weighing two kgs and above.